Epigallocatechin-3-gallate inhibits nicotine-induced migration and invasion by the suppression of angiogenesis and epithelial-mesenchymal transition in non-small cell lung cancer cells

Pesch, 2012, Cigarette smoking and lung cancer - relative risk estimates for the major histological types from a pooled analysis of case-control studies, Int J Cancer, 131, 1210, 10.1002/ijc.27339

Schaal, 2014, Nicotine-mediated cell proliferation and tumor progression in smoking-related cancers, Mol Cancer Res, 12, 14, 10.1158/1541-7786.MCR-13-0541

Nair, 2014, Nicotine-mediated invasion and migration of non-small cell lung carcinoma cells by modulating STMN3 and GSPT1 genes in an ID1-dependent manner, Mol Cancer, 13, 173, 10.1186/1476-4598-13-173

Dasgupta, 2009, Nicotine induces cell proliferation, invasion and epithelial-mesenchymal transition in a variety of human cancer cell lines, Int J Cancer, 124, 36, 10.1002/ijc.23894

Wu, 2013, Silencing of periostin inhibits nicotine-mediated tumor cell growth and epithelial-mesenchymal transition in lung cancer cells, Mol Med Rep, 7, 875, 10.3892/mmr.2013.1267

Jackson, 2010, HIF, hypoxia and the role of angiogenesis in non-small cell lung cancer, Expert Opin Ther Targets, 14, 1047, 10.1517/14728222.2010.511617

Creighton, 2013, The role of epithelial-mesenchymal transition programming in invasion and metastasis: A clinical perspective, Cancer Manag Res, 5, 187, 10.2147/CMAR.S35171

Zhang, 2007, Nicotine induces hypoxia-inducible factor-1alpha expression in human lung cancer cells via nicotinic acetylcholine receptor-mediated signaling pathways, Clin Cancer Res, 13, 4686, 10.1158/1078-0432.CCR-06-2898

Ma, 2014, α5 nicotinic acetylcholine receptor mediates nicotineinduced HIF-1α and VEGF expression in non-small cell lung cancer, Toxicol Appl Pharmacol, 278, 172, 10.1016/j.taap.2014.04.023

Nurwidya, 2012, Epithelial mesenchymal transition in drug resistance and metastasis of lung cancer, Cancer Res Treat, 44, 151, 10.4143/crt.2012.44.3.151

Wang, 2014, Tea consumption and lung cancer risk: A meta-analysis of case-control and cohort studies, Nutrition, 30, 1122, 10.1016/j.nut.2014.02.023

Lin, 2012, Smoking, green tea consumption, genetic polymorphisms in the insulin-like growth factors and lung cancer risk, PLoS One, 7, e30951, 10.1371/journal.pone.0030951

Ravindranath, 2009, differential growth suppression of human melanoma cells by tea (Camellia sinensis) epicatechins (ECG, EGC and EGCG), Evid Based Complement Alternat Med, 6, 523, 10.1093/ecam/nem140

Du, 2012, Epigallocatechin gallate (EGCG) is the most effective cancer chemopreventive polyphenol in green tea, Nutrients, 4, 1679, 10.3390/nu4111679

Wang, 2014, Epigallocatechin-3-gallate inhibits the proliferation and migration of human ovarian carcinoma cells by modulating p38 kinase and matrix metallo-proteinase-2, Mol Med Rep, 9, 1085, 10.3892/mmr.2014.1909

Zhang, 2014, Effects of epigallocatechin gallate on the proliferation and apoptosis of the nasopharyngeal carcinoma cell line CNE2, Exp Ther Med, 8, 1783, 10.3892/etm.2014.2020

Li, 2014, Epigallocatechin-3-gallate induces apoptosis, inhibits proliferation and decreases invasion of glioma cell, Neurosci Bull, 30, 67, 10.1007/s12264-013-1394-z

Li, 2013, Epigallocatechin-3-gallate inhibits IGF-I-stimulated lung cancer angiogenesis through downregulation of HIF-1α and VEGF expression, J Nutrigenet Nutrigenomics, 6, 169, 10.1159/000354402

Zhang, 2006, Green tea extract and (−)-epigallocatechin-3-gallate inhibit hypoxia- and serum-induced HIF-1alpha protein accumulation and VEGF expression in human cervical carcinoma and hepatoma cells, Mol Cancer Ther, 5, 1227, 10.1158/1535-7163.MCT-05-0490

He, 2013, (−)-Epigallocatechin-3-gallate inhibits human papillomavirus (HPV)-16 oncoprotein-induced angiogenesis in non-small cell lung cancer cells by targeting HIF-1α, Cancer Chemother Pharmacol, 71, 713, 10.1007/s00280-012-2063-z

Liu, 2012, EGCG inhibits transforming growth factor-β-mediated epithelial-to-mesenchymal transition via the inhibition of Smad2 and Erk1/2 signaling pathways in nonsmall cell lung cancer cells, J Agric Food Chem, 60, 9863, 10.1021/jf303690x

Ko, 2013, TGF-β1-induced epithelial-mesenchymal transition and acetylation of Smad2 and Smad3 are negatively regulated by EGCG in human A549 lung cancer cells, Cancer Lett, 335, 205, 10.1016/j.canlet.2013.02.018

Takahashi, 2014, Mechanism-based inhibition of cancer metastasis with (−)-epigal-locatechin gallate, Biochem Biophys Res Commun, 443, 1, 10.1016/j.bbrc.2013.10.094

Nilsson, 2004, differential activation of vascular genes by hypoxia in primary endothelial cells, Exp Cell Res, 299, 476, 10.1016/j.yexcr.2004.06.005

Li, 2011, Overexpression of human papillomavirus (HPV) type 16 oncoproteins promotes angiogenesis via enhancing HIF-1α and VEGF expression in non-small cell lung cancer cells, Cancer Lett, 311, 160, 10.1016/j.canlet.2011.07.012

Skinner, 2004, Vascular endothelial growth factor transcriptional activation is mediated by hypoxia-inducible factor 1alpha, HDM2, and p70S6K1 in response to phosphatidylinositol 3-kinase/AKT signaling, J Biol Chem, 279, 45643, 10.1074/jbc.M404097200

Wang, 2013, CIP2A expression is associated with altered expression of epithelial-mesenchymal transition markers and predictive of poor prognosis in pancreatic ductal adenocarcinoma, Tumour Biol, 34, 2309, 10.1007/s13277-013-0775-2

Zhao, 2013, Expression of integrin-linked kinase in adenoid cystic carcinoma of salivary glands correlates with epithelial-mesenchymal transition markers and tumor progression, Med Oncol, 30, 619, 10.1007/s12032-013-0619-3

Balanis, 2013, Epithelial to mesenchymal transition promotes breast cancer progression via a fibronectin-dependent STAT3 signaling pathway, J Biol Chem, 288, 17954, 10.1074/jbc.M113.475277

Xing, 2013, Small interfering RNA targeting ILK inhibits metastasis in human tongue cancer cells through repression of epithelial-to-mesenchymal transition, Exp Cell Res, 319, 2058, 10.1016/j.yexcr.2013.05.014

López-Novoa, 2009, Inflammation and EMT: An alliance towards organ fibrosis and cancer progression, EMBO Mol Med, 1, 303, 10.1002/emmm.200900043

Pirozzi, 2011, Epithelial to mesenchymal transition by TGFβ-1 induction increases stemness characteristics in primary non small cell lung cancer cell line, PLoS One, 6, e21548, 10.1371/journal.pone.0021548

Kim, 2013, Alteration of the E-cadherin/β-catenin complex is an independent poor prognostic factor in lung adenocarcinoma, Korean J Pathol, 47, 44, 10.4132/KoreanJPathol.2013.47.1.44

Zhan, 2013, Expression of Rac1, HIF-1α, and VEGF in gastric carcinoma: Correlation with angiogenesis and prognosis, Onkologie, 36, 102, 10.1159/000348525

Simonetti, 2013, Microvessel density and VEGF, HIF-1α expression in primary oral melanoma: Correlation with prognosis, Oral dis, 19, 620, 10.1111/odi.12048

Kang, 2013, Hypoxia-inducible factor-1α overexpression indicates poor clinical outcomes in tongue squamous cell carcinoma, Exp Ther Med, 5, 112, 10.3892/etm.2012.779

Zhang, 2013, Hypoxia induces epithelial-mesenchymal transition via activation of SNAI1 by hypoxia-inducible factor -1α in hepatocellular carcinoma, BMC Cancer, 13, 108, 10.1186/1471-2407-13-108

Ning, 2013, Vascular endothelial growth factor receptor-1 activation promotes migration and invasion of breast cancer cells through epithelial-mesenchymal transition, PLoS One, 8, e65217, 10.1371/journal.pone.0065217

Semenza, 2010, Defining the role of hypoxia-inducible factor 1 in cancer biology and therapeutics, Oncogene, 29, 625, 10.1038/onc.2009.441

Jiang, 2009, An algorithm for identifying novel targets of transcription factor families: Application to hypoxia-inducible factor 1 targets, Cancer Inform, 7, 75, 10.4137/CIN.S1054

Kaidi, 2006, Direct transcriptional up-regulation of cyclooxygenase-2 by hypoxia-inducible factor (HIF)-1 promotes colorectal tumor cell survival and enhances HIF-1 transcriptional activity during hypoxia, Cancer Res, 66, 6683, 10.1158/0008-5472.CAN-06-0425

Obacz, 2013, Cross-talk between HIF and p53 as mediators of molecular responses to physiological and genotoxic stresses, Mol Cancer, 12, 93, 10.1186/1476-4598-12-93

Zhang, 2014, Roles of PI3K/Akt and c-Jun signaling pathways in human papillomavirus type 16 oncoprotein-induced HIF-1α, VEGF, and IL-8 expression and in vitro angiogenesis in non-small cell lung cancer cells, PLoS One, 9, e103440, 10.1371/journal.pone.0103440

Yu, 2014, CXCR7 signaling induced epithelial-mesenchymal transition by AKT and ERK pathways in epithelial ovarian carcinomas, Tumour Biol

Wojtalla, 2011, Targeting phosphoinositide 3-kinase signalling in lung cancer, Crit Rev Oncol Hematol, 80, 278, 10.1016/j.critrevonc.2011.01.007

Zhang, 2014, Tumor hypoxia enhances non-small cell lung cancer metastasis by selectively promoting macrophage M2 polarization through the activation of ERK signaling, Oncotarget Oct, 5, 9664, 10.18632/oncotarget.1856

Beck, 2014, Targeting the phosphatidylinositol 3-kinase (PI3K)/AKT/mammalian target of rapamycin (mTOR) pathway: An emerging treatment strategy for squamous cell lung carcinoma, Cancer Treat Rev, 40, 980, 10.1016/j.ctrv.2014.06.006

Stinchcombe, 2014, MEK inhibition in non-small cell lung cancer, Lung Cancer, 86, 121, 10.1016/j.lungcan.2014.09.005